CPOAX
Price
$42.54
Change
+$0.86 (+2.06%)
Updated
Jun 6 closing price
Net Assets
1.4B
RGEBX
Price
$75.21
Change
+$0.72 (+0.97%)
Updated
Jun 6 closing price
Net Assets
304.87B
Interact to see
Advertisement

CPOAX vs RGEBX

Header iconCPOAX vs RGEBX Comparison
Open Charts CPOAX vs RGEBXBanner chart's image
Morgan Stanley Insight A
Price$42.54
Change+$0.86 (+2.06%)
VolumeN/A
Net Assets1.4B
American Funds Growth Fund of Amer R2E
Price$75.21
Change+$0.72 (+0.97%)
VolumeN/A
Net Assets304.87B
CPOAX vs RGEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CPOAX vs. RGEBX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPOAX is a Buy and RGEBX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 305B vs. CPOAX (1.41B). CPOAX pays higher dividends than RGEBX: CPOAX (0.56) vs RGEBX (0.00). CPOAX was incepted earlier than RGEBX: CPOAX (28 years) vs RGEBX (11 years). CPOAX (1.15) is less costly to investors than RGEBX (1.09). CPOAX is a more actively managed with annual turnover of: 44.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than CPOAX: RGEBX (250) vs CPOAX (1000). CPOAX annual gain was more profitable for investors over the last year : 64.27 vs. RGEBX (8.53). RGEBX return over 5 years is better than : 41.54 vs. CPOAX (-25.51).
CPOAXRGEBXCPOAX / RGEBX
Total Expense Ratio1.151.09106%
Annual Report Gross Expense Ratio1.151.09106%
Fund Existence28 years11 years-
Gain YTD8.5425.277162%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.41B305B0%
Annual Yield % from dividends0.560.00-
Returns for 1 year64.278.53754%
Returns for 3 years31.4635.3289%
Returns for 5 years-25.5141.54-61%
Returns for 10 years22.3667.9933%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNSP1.040.03
+2.97%
CNS Pharmaceuticals Inc.
XIFR8.910.25
+2.89%
XPLR Infrastructure LP
INSM73.620.88
+1.21%
Insmed
IKT1.96N/A
N/A
Inhibikase Therapeutics
TK8.61-0.11
-1.26%
Teekay Corporation Ltd